BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38214314)

  • 1. The impact of cannabidiol placebo on responses to an acute stressor: A replication and proof of concept study.
    Zhekova RM; Perry RN; Spinella TC; Dockrill K; Stewart SH; Barrett SP
    J Psychopharmacol; 2024 Jan; 38(1):116-124. PubMed ID: 38214314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study.
    Spinella TC; Stewart SH; Naugler J; Yakovenko I; Barrett SP
    Psychopharmacology (Berl); 2021 Jul; 238(7):1965-1977. PubMed ID: 33813611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Cannabidiol Expectancy on Cortisol Responsivity in the Context of Acute Stress: Associations with Biological Sex.
    Spinella TC; Burdeyny V; Oprea A; Perrot TS; Barrett SP
    Cannabis Cannabinoid Res; 2023 Aug; ():. PubMed ID: 37552817
    [No Abstract]   [Full Text] [Related]  

  • 4. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study.
    Bloomfield MAP; Yamamori Y; Hindocha C; Jones APM; Yim JLL; Walker HR; Statton B; Wall MB; Lees RH; Howes OD; Curran VH; Roiser JP; Freeman TP
    Psychopharmacology (Berl); 2022 May; 239(5):1539-1549. PubMed ID: 35445839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder.
    Bolsoni LM; Crippa JAS; Hallak JEC; Guimarães FS; Zuardi AW
    Psychopharmacology (Berl); 2022 May; 239(5):1499-1507. PubMed ID: 35029706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial.
    Gournay LR; Ferretti ML; Bilsky S; Vance E; Nguyen AM; Mann E; Williams P; Leen-Feldner EW
    Psychopharmacology (Berl); 2023 Oct; 240(10):2147-2161. PubMed ID: 37552290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cannabidiol (CBD) on regional cerebral blood flow.
    Crippa JA; Zuardi AW; Garrido GE; Wichert-Ana L; Guarnieri R; Ferrari L; Azevedo-Marques PM; Hallak JE; McGuire PK; Filho Busatto G
    Neuropsychopharmacology; 2004 Feb; 29(2):417-26. PubMed ID: 14583744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.
    Appiah-Kusi E; Petros N; Wilson R; Colizzi M; Bossong MG; Valmaggia L; Mondelli V; McGuire P; Bhattacharyya S
    Psychopharmacology (Berl); 2020 Apr; 237(4):1121-1130. PubMed ID: 31915861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
    Bergamaschi MM; Queiroz RH; Chagas MH; de Oliveira DC; De Martinis BS; Kapczinski F; Quevedo J; Roesler R; Schröder N; Nardi AE; Martín-Santos R; Hallak JE; Zuardi AW; Crippa JA
    Neuropsychopharmacology; 2011 May; 36(6):1219-26. PubMed ID: 21307846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabidiol on psychosocial stress, situational anxiety and nausea in a virtual reality environment: a protocol for a single-centre randomised clinical trial.
    Bawa Z; McCartney D; Bedoya-Pérez M; Lau NS; Fox R; MacDougall H; McGregor IS
    BMJ Open; 2024 Mar; 14(3):e082927. PubMed ID: 38531572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.
    Martin-Santos R; Crippa JA; Batalla A; Bhattacharyya S; Atakan Z; Borgwardt S; Allen P; Seal M; Langohr K; Farré M; Zuardi AW; McGuire PK
    Curr Pharm Des; 2012; 18(32):4966-79. PubMed ID: 22716148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Double-Blind, Randomized, Placebo-Controlled Test of the Effects of Cannabidiol on Experiences of Test Anxiety Among College Students.
    Stanley TB; Ferretti ML; Bonn-Miller MO; Irons JG
    Cannabis Cannabinoid Res; 2023 Dec; 8(6):1090-1099. PubMed ID: 35861792
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of cannabidiol-rich hemp extract oil on reconsolidation disruption of naturalistic interoceptive aversive memory in humans: Protocol for a randomized clinical trial.
    Zaizar ED; Papini S; O'Connor P; Telch MJ
    Contemp Clin Trials; 2022 Aug; 119():106847. PubMed ID: 35811050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Cannabidiol (CBD) oil in the treatment of PTSD: Study design and rationale for a placebo-controlled randomized clinical trial.
    Telch MJ; Fischer CM; Zaizar ED; Rubin M; Papini S
    Contemp Clin Trials; 2022 Nov; 122():106933. PubMed ID: 36154908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD).
    Hardy J; Greer R; Huggett G; Kearney A; Gurgenci T; Good P
    J Clin Oncol; 2023 Mar; 41(7):1444-1452. PubMed ID: 36409969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
    Hurd YL; Spriggs S; Alishayev J; Winkel G; Gurgov K; Kudrich C; Oprescu AM; Salsitz E
    Am J Psychiatry; 2019 Nov; 176(11):911-922. PubMed ID: 31109198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
    Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
    Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
    Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
    Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.